Flowers Foods: The Reset Is Priced In, but Sourdough Has Two Quarters to Prove It

Flowers Foods cut its quarterly dividend almost in half this spring — from $0.2475 a share to $0.125, a level it last paid in 2008 — and then watched its stock slide again after second-quarter earnings in August. The shares now trade near $7, down more than 50% from about $15 a year ago and within a dime or two of the $6.80 52-week low they touched the day after the report. A 7% dividend yield and earnings at roughly 9 times are the classic ingredients of either a real reset or a value trap, and the company — the second-largest U.S. packaged baker, behind only the private Bimbo Bakeries — has stacked up evidence for both readings at the same time.

Start with the quarter that just reset expectations. In the 12 weeks ended July 18, Flowers sold $1.193 billion, 4.0% less than a year earlier, as total volume fell 5.8% and pricing and mix added back only 1.8%. The damage is concentrated exactly where the company lives: fresh packaged bread volume fell 9.5% in the quarter. Adjusted EBITDA dropped 19% to $111.3 million, a 9.3% margin, and adjusted earnings per share fell to $0.21, short of the $0.24 analysts expected. Management responded by cutting its fiscal 2026 guidance again — adjusted EPS now $0.75 to $0.85, down from $0.80 to $0.90 — the latest in a string of downward revisions that began last year.

It is worth understanding why profit falls four times as fast as sales, because that mechanism is the whole contest. Bread is a fixed-cost business: Flowers runs 44 bakeries and a direct-store-delivery network that reaches roughly 85% of the U.S. population, and those costs do not shrink when a route sells fewer loaves. Management held the line on price — gross margin stayed near 48% — so the volume shortfall ran straight through to the operating layer, and the marketing budget went up on top. Shrinking volume, a fixed cost base, and relaunch spending is how a 4% sales decline becomes a 19% EBITDA decline.

The harder fact is that the bread aisle itself is wilting, not just Flowers. Stretched household budgets are pushing shoppers toward private label and smaller, more differentiated loaves. One investor analysis published this year put Flowers' share of packaged bread at roughly 17% of the category by 2024, down from about 24% in 2019, with traditional loaves still about three-quarters of the company's revenue. Meanwhile the demand that does exist has rotated toward sourdough, protein breads and half-loaves.

That rotation is the sourdough "lean." Management sizes sourdough as a roughly $1.3 billion sub-category with "pretty remarkable" growth — and concedes Flowers is underpenetrated there, noting that even its premium Dave's Killer Bread line sells sourdough only on the West Coast. So the portfolio is being rebuilt around the growth. Nature's Own, its largest brand, was relaunched in May with simpler ingredients and a Non-GMO Project Verified claim — its first major launch in well over a decade — and the sourdough "Perfectly Crafted" items in that line sold more than 8% higher. New sourdough, protein and half-loaf products are scheduled from the back half of 2026 through spring 2027. And Simple Mills, the better-for-you snack brand Flowers paid $795 million for in early 2025, grew retail sales 13% in the quarter, with cookies up 39%.

Now the audit, because a growth claim only counts against the size of the problem it must offset. Simple Mills generated $213.9 million of Flowers' $5.256 billion in fiscal 2025 sales — under 5% — and lost $14.4 million doing it. Even strong growth there adds a few tens of millions a year, a rounding error against the hundreds of millions of volume the core is giving up, and management said the Nature's Own relaunch is "too early to see results read through." The sourdough pivot is a reason the decline can slow; it is not yet evidence that it has.

What actually drove the crash, though, was not the bread erosion by itself — it was the balance sheet. The Simple Mills deal added leverage on top of a shrinking core. Long-term debt stood at $1.686 billion at the end of the quarter, S&P Global downgraded Flowers to BBB- in November 2025 citing high leverage and falling loaf volumes, and $400 million of 3.5% senior notes were due in October of this year. Against that, the dividend reset reads as honest management: paying out $209 million a year in dividends while free cash flow shrank was no longer credible.

And this half of the story so far is execution, not promise. Halving the payout frees on the order of $100 million a year — the new $0.50 annual dividend costs about $107 million against the $209 million paid in fiscal 2025. Flowers has paid down roughly $70 million of debt year to date, replaced the looming October maturity with a new $400 million delayed-draw facility in the spring, and set a target of below 3 times leverage by fiscal 2027. The lower dividend is now covered about three times by free cash flow, which turns the ~7% yield from a hope into a floor — provided the business stops getting worse. A cost program adds an expected $9 million in the second half and a $20 million tailwind into 2027.

That last clause is the whole question, and it is already in the price. At about $7, Flowers trades under 9 times the midpoint of its own reduced adjusted-EPS guidance and around 6.5 to 7 times forward EBITDA — a steep discount to packaged-food peers such as General Mills and J.M. Smucker, which trade nearer 24 times and 15 times trailing EBITDA. But the market is not giving Flowers credit for the reset; it is pricing another leg down. The cleaner comparison is the stock's reset against the business's reset. The share price has fallen more than 50% over the past year while guided earnings have fallen about 25% from fiscal 2025's $1.09 to the new range's midpoint — and part of even that gap is calendar, since fiscal 2026 has one fewer week than the 53-week prior year. The multiple, not just the earnings, was repriced. That is the arithmetic a risk/reward reset needs — if the operating reality stops falling.

The proof has a clock on it. Management's own guidance says the third quarter will still be down year over year, and that the fourth quarter is where the year is supposed to stabilize: the Nature's Own relaunch, Simple Mills acceleration, and new sourdough and protein products hitting shelves through spring 2027. Two quarters from now you will be able to see whether the new volume plus Simple Mills is offsetting enough bread decline to flatten the year. If fresh bread keeps contracting at high single digits and guidance comes down a third time, the cheap multiple will have been cheap for a reason. If it does not, a credible ~7% yield, roughly $300 million of free cash flow, and a balance sheet on a repair path will have made this the year the market finally found the floor.

For a retail investor, the honest posture is a watch with defined proof points, not yet a conviction buy. The balance-sheet fire that caused most of the crash is being extinguished with actual cash, and the price now discounts more damage than the company's own forecast shows — the risk/reward has genuinely reset. But cheap does not finish the argument against a category that is shrinking and a growth portfolio still too small to carry it. Flowers is a cheap turnaround with two quarters to prove it is one.